| Product NDC: | 0406-9206 |
| Proprietary Name: | FENTANYL CITRATE |
| Non Proprietary Name: | FENTANYL CITRATE |
| Active Ingredient(s): | 600 ug/1 & nbsp; FENTANYL CITRATE |
| Administration Route(s): | TRANSMUCOSAL |
| Dosage Form(s): | LOZENGE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0406-9206 |
| Labeler Name: | Mallinckrodt Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078907 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100115 |
| Package NDC: | 0406-9206-30 |
| Package Description: | 30 BLISTER PACK in 1 CARTON (0406-9206-30) > 1 LOZENGE in 1 BLISTER PACK |
| NDC Code | 0406-9206-30 |
| Proprietary Name | FENTANYL CITRATE |
| Package Description | 30 BLISTER PACK in 1 CARTON (0406-9206-30) > 1 LOZENGE in 1 BLISTER PACK |
| Product NDC | 0406-9206 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | FENTANYL CITRATE |
| Dosage Form Name | LOZENGE |
| Route Name | TRANSMUCOSAL |
| Start Marketing Date | 20100115 |
| Marketing Category Name | ANDA |
| Labeler Name | Mallinckrodt Inc. |
| Substance Name | FENTANYL CITRATE |
| Strength Number | 600 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |